Stock News! First Company In The U.S. Granted Over The Counter CBD Rights

This company is bringing cannabis to the pain relief market, and the market is projected to Exceed 13 billion by 2025.

This company has a running start and other companies looking to gain some traction in the CBD pain relief market , and have registered approval with the FDA for medical claims.

They have secured more purchasing contracts with CVS and have plans to further penetrate the U.S Markets.

We specialize in investing in what we call non-traditional assets

The reason why we call that is we’re talking about stuff that you don’t find on the New York Stock Exchange.

So the typical response when people think about investing is “I don’t have enough money”

and the reason why they think that is because typically someone would need a $100k or even move to the needle

So then it’s like what’s the point…

So for us, that wasn’t good enough for our team and in looking to find something better we’ve scoured the world looking for what we call non-traditional investments; so I mean oil & gas fields, gold & silver mines, cryptocurrencies, cannabis, options & stock trading and distressed real estate; I mean you name it we’ve pretty much tried it trying to get better than average returns…

Regarding mutual or index funds.

We recommend that everyone have some as part of a diversified asset allocation strategy

We address that with other videos on the channel.

Those don’t really excite us because for those types of investments you need $100k to make a few thousand

FREE Class: A Passive System for Investing and Building Wealth in the Green Rush: https://invest.jarviz.io

#Abacus Health


Leave a Reply

Your email address will not be published. Required fields are marked *